| Literature DB >> 26257172 |
Claudia Gonzaga-Jauregui1, Tamar Harel2, Tomasz Gambin2, Maria Kousi3, Laurie B Griffin4, Ludmila Francescatto3, Burcak Ozes5, Ender Karaca2, Shalini N Jhangiani6, Matthew N Bainbridge6, Kim S Lawson7, Davut Pehlivan2, Yuji Okamoto2, Marjorie Withers2, Pedro Mancias8, Anne Slavotinek9, Pamela J Reitnauer10, Meryem T Goksungur11, Michael Shy12, Thomas O Crawford13, Michel Koenig14, Jason Willer3, Brittany N Flores15, Igor Pediaditrakis3, Onder Us16, Wojciech Wiszniewski2, Yesim Parman11, Anthony Antonellis17, Donna M Muzny6, Nicholas Katsanis3, Esra Battaloglu5, Eric Boerwinkle18, Richard A Gibbs19, James R Lupski20.
Abstract
Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous distal symmetric polyneuropathy. Whole-exome sequencing (WES) of 40 individuals from 37 unrelated families with CMT-like peripheral neuropathy refractory to molecular diagnosis identified apparent causal mutations in ∼ 45% (17/37) of families. Three candidate disease genes are proposed, supported by a combination of genetic and in vivo studies. Aggregate analysis of mutation data revealed a significantly increased number of rare variants across 58 neuropathy-associated genes in subjects versus controls, confirmed in a second ethnically discrete neuropathy cohort, suggesting that mutation burden potentially contributes to phenotypic variability. Neuropathy genes shown to have highly penetrant Mendelizing variants (HPMVs) and implicated by burden in families were shown to interact genetically in a zebrafish assay exacerbating the phenotype established by the suppression of single genes. Our findings suggest that the combinatorial effect of rare variants contributes to disease burden and variable expressivity.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26257172 PMCID: PMC4545408 DOI: 10.1016/j.celrep.2015.07.023
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423